| The
Professors' Posts Anemia
|
|
| SUSAN LECLAIR |
|
||
|
Terry Hamblin 19th June 2005 |
Anemia caused by IHA, marrow failure or MDS. Immune hemolytic anemia (in this case the same as AIHA) is diagnosable by the presence of a positive direct Coombs test (or antiglobulin test). You would also expect to see reduced haptoglobins, increased urinary urobilinogen and increased reticulocytes. MDS is a form of bone marrow failure. A blood film might be expected to show the characteristic features - irregularly shaped red cells, hypogranular neutrophils, uni- and bi-lobed meutrophils, giant agranular platelets, but it is best diagnosed by a bone marrow. Here the changes in the size and shapes of developing blood cells would be easier to recognise and in addition chromosomal analysis should be done since the features of secondary MDS are well recognised. Another possible diagnosis is marrow infiltration with CLL, and this will onjly be diagnosed by a bone marrow biopsy. Patients who have low levels of platelets, neutrophils and red cells after treatment for CLL are in a difficult diagnostic situation. It could be an immune effect, but this should be easy to diagnose. The alternative is that the treatment has damaged the bone marrow stem cells. This could either mean that few if any blood cells can be produced or it could mean that the cells that are produced cannot mature properly into full-grown blood cells. The latter is MDS and is recognised by what the cells look like down a microscope. There is little that can be done in either situation except supportive care, which generally means blood transfusions, perhaps with platelet transfusions and antibiotics when necessary. New drugs for MDS such as 5-azacytidine and Revlimid have not been shown to be of value in secondary MDS. |